SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. (OTC:BCDA) today announced publication of a study in the International Heart Journal.1 According to the study, delivery of stem cell therapy to the heart using the Helix™transendocardial delivery system results in superior cell delivery than either percutaneous intra-coronary infusion or direct injection in an open […]
Coronary/Structural Heart
Is it Possible to Give Yourself a Heart Attack?
By Ken Dropiewski It turns out; our mothers may have been onto something when they said, “you are going to give me a heart attack.” Data from the Interheart study is supportive of the theory that you can significantly increase the risk of a cardiac event like AMI, simply by […]
Heartit And Siemens Healthineers (SI) Agree To Jointly Sell The Precession CMR Workflow Solution
DURHAM, N.C., May 23, 2017 /PRNewswire/ — Heart Imaging Technologies, LLC (HeartIT) and Siemens Healthineers have agreed to cooperatively sell the latest version of HeartIT’s Precession cardiovascular magnetic resonance (CMR) workflow solution. Precession is the first browser-based CMR solution to combine medical image viewing, analysis, and reporting into one comprehensive, cloud-based […]
Gore Announces Positive Results from REDUCE Clinical Study for PFO Closure
Study met its primary endpoint with PFO closure in conjunction with antiplatelet therapy, reducing recurrent stroke by > 75% over antiplatelet therapy alone Share: Twitter Linked In Source W. L. Gore Press Release FLAGSTAFF, Ariz. (May 16, 2017) – W. L. Gore & Associates, Inc. (Gore) announces positive results from its […]
Edwards’ Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes
PARIS, May 17, 2017 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced late-breaking data at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter aortic valve replacement (TAVR) patients treated with the Edwards CENTERA valve. These new […]
Head-to-Head Study Validates Consistent Performance of Microcatheter FFR
PARIS & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–ACIST Medical Systems Inc., a Bracco Group Company, today announced results from the ACIST-FFR Study (Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement) demonstrating the consistent and correlative performance of the Navvus® MicroCatheter compared to standard pressure wire systems. ACIST-FFR is […]
Teleflex to Introduce the New Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump and the Product Portfolio from the Recently Acquired Vascular Solutions, Inc. at the European Association for Percutaneous Cardiovascular Interventions Course (EuroPCR)
WAYNE, Pa.–(BUSINESS WIRE)–May 15, 2017– Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase its complex PCI product portfolio recently acquired from the purchase of Vascular Solutions and the new Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) at the EuroPCR […]
Edwards Lifesciences (EW)’ Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes
PARIS, May 17, 2017 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced late-breaking data at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter aortic valve replacement (TAVR) patients treated with the Edwards CENTERA valve. These new […]
Acist Medical Systems, Inc. Release: Head-to-Head Study Validates Consistent Performance Of Microcatheter FFR
PARIS & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–ACIST Medical Systems Inc., a Bracco Group Company, today announced results from the ACIST-FFR Study (Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement) demonstrating the consistent and correlative performance of the Navvus® MicroCatheter compared to standard pressure wire systems. ACIST-FFR is […]
Elixir Medical Announces Outstanding 5-Year Clinical Data For CE Mark-Approved Desolve Novolimus Eluting Bioresorbable Coronary Scaffold System
MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, today announced excellent 5-year clinical data from the DESolve Nx international pivotal clinical trial for the CE Mark-approved, fully bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System. Stefan Verheye, MD, PhD, ZNA Middleheim Hospital, […]


